|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: VISTA MEDICAL TECHNOLOGIES INC, 10-Q, 2000-08-03 |
Next: VISTA MEDICAL TECHNOLOGIES INC, 10-Q, EX-27.1, 2000-08-03 |
<PAGE>
EXHIBIT 11.1
VISTA MEDICAL TECHNOLOGIES, INC.
STATEMENT REGARDING COMPUTATION OF PER SHARE DATA
<TABLE>
<CAPTION>
Three Months Ended June 30, Six Months Ended June 30,
------------------------------- -----------------------------
2000 1999 2000 1999
------------- --------------- ------------- ------------
<S> <C> <C> <C> <C>
Net income (loss) ............................................. $ (966,303) $ (3,289,139) $ (1,963,270) $ (5,958,470)
Weighted average common shares outstanding .................... 19,144,183 13,605,782 16,420,862 13,537,059
------------- --------------- ------------- ------------
Shares used in basic and diluted loss per share ............... 19,144,183 13,605,782 16,420,862 13,537,059
============= =============== ============= ============
Basic and diluted loss per share .............................. $ (0.05) $ (0.24) $ (0.12) $ (0.44)
============= =============== ============= ============
</TABLE>
|
|